BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY...
BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines
About this item
Full title
BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines
Author / Creator
Anderson, N M , Harrold, I , Mansour, M R , Sanda, T , McKeown, M , Nagykary, N , Bradner, J E , Lan Zhang, G , Look, A T and Feng, H
Publisher
London: Nature Publishing Group UK
Journal title
Leukemia, 2014-05, Vol.28 (5), p.1145-1148
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Alternative Titles
Full title
BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4013222
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4013222
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2013.377
